Chinese healthcare-focused GP HighLight Capital is set to exit its position in US-based biotechnology company Bonti after Allergan agreed to acquire the business for $195 million, plus additional payments if certain development targets are met.
HighLight first backed Bonti in early 2017, leading the extension to a Series B round worth $11.7 million in total. It then led a $15.5 million Series C at the beginning of this year. The company already...
Novo Tellus Capital Partners has invested S$12 million ($8.8 million) in Procurri, a Singapore-listed provider of IT services and data center equipment.
Australia’s Anacacia Capital has realized the final exit from its debut fund with the sale of its majority stake in workplace equipment provider RIS Safety to domestic investor Bricktop Group.
Bain Capital has acquired a majority interest in the data center construction and maintenance division of Shenzhen-listed NetScience Technology for RMB990 million ($147 million).
Shukun, a Chinese company that provides artificial intelligence (AI) technology used in the treatment of cardiovascular diseases, has raised RMB200 million ($29 million) in a Series B round led by China Creation Ventures.